# Nouvelle Ivoire Cosmetique NICOS · 66-41 · IVORY COAST — FDA import alert red lists: firms subject to detention without physical examination

For Nouvelle Ivoire Cosmetique NICOS · 66-41 · IVORY COAST, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is IVORY COAST; product is PIMENT Doux plus FACE WHITENING CREAM | PIMENT Doux plus FACE WHITENING CREAM; product code is 53 L - - 06 Moisturizing (Skin Care Preparations) | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 04/10/2024; address is 03 BP 659 Abidjan 03 , Abidjan, IVORY COAST, verified against its source on 2026-09-16.

- **Firm:** Nouvelle Ivoire Cosmetique NICOS _(verified: appears in the quote below)_
- **Import alert:** 66-41
- **Import alert name:** Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- **Country:** IVORY COAST _(verified: appears in the quote below)_
- **Address:** 03 BP 659 Abidjan 03 , Abidjan, IVORY COAST _(verified: appears in the quote below)_
- **Date published:** 04/10/2024 _(verified: appears in the quote below)_
- **Product code:** 53 L - - 06 Moisturizing (Skin Care Preparations) | 66 V - - 99 Miscellaneous Patent Medicines, Etc. _(verified: each item appears in the quote below)_
- **Product:** PIMENT Doux plus FACE WHITENING CREAM | PIMENT Doux plus FACE WHITENING CREAM _(verified: each item appears in the quote below)_
- **FDA notes:** Products appear to be new drugs as defined by section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 321(g)(1). As such, “PIMENT Doux plus FACE WHITENING CREAM” appears to be an unapproved new drug in violation of section 505(a) of the FD&C Act, 21 U.S.C. 355(a). Introduction or delivery for introduction of “PIMENT Doux plus FACE WHITENING CREAM” into interstate commerce violates sections 301(d) and (a) of the FD&C Act, 21 U.S.C. 331(d) and (a). Based on its labeled intended uses, “PIMENT Doux plus FACE WHITENING CREAM” is a “drug” as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Specifically, this product is intended for use as a skin bleaching drug product. | Products appear to be new drugs as defined by section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 321(g)(1). As such, “PIMENT Doux plus FACE WHITENING CREAM” appears to be an unapproved new drug in violation of section 505(a) of the FD&C Act, 21 U.S.C. 355(a). Introduction or delivery for introduction of “PIMENT Doux plus FACE WHITENING CREAM” into interstate commerce violates sections 301(d) and (a) of the FD&C Act, 21 U.S.C. 331(d) and (a). Based on its labeled intended uses, “PIMENT Doux plus FACE WHITENING CREAM” is a “drug” as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Specifically, this product is intended for use as a skin bleaching drug product. _(verified: each item appears in the quote below)_

## What the source says

> Nouvelle Ivoire Cosmetique NICOS Date Published : 04/10/2024 03 BP 659 Abidjan 03 , Abidjan, IVORY COAST 53 L - - 06 Moisturizing (Skin Care Preparations) Date Published: 04/10/2024 Desc: PIMENT Doux plus FACE WHITENING CREAM Notes: Products appear to be new drugs as defined by section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 321(g)(1). As such, “PIMENT Doux plus FACE WHITENING CREAM” appears to be an unapproved new drug in violation of section 505(a) of the FD&C Act, 21 U.S.C. 355(a). Introduction or delivery for introduction of “PIMENT Doux plus FACE WHITENING CREAM” into interstate commerce violates sections 301(d) and (a) of the FD&C Act, 21 U.S.C. 331(d) and (a). Based on its labeled intended uses, “PIMENT Doux plus FACE WHITENING CREAM” is a “drug” as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Specifically, this product is intended for use as a skin bleaching drug product. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 04/10/2024 Desc: PIMENT Doux plus FACE WHITENING CREAM Notes: Products appear to be new drugs as defined by section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 321(g)(1). As such, “PIMENT Doux plus FACE WHITENING CREAM” appears to be an unapproved new drug in violation of section 505(a) of the FD&C Act, 21 U.S.C. 355(a). Introduction or delivery for introduction of “PIMENT Doux plus FACE WHITENING CREAM” into interstate commerce violates sections 301(d) and (a) of the FD&C Act, 21 U.S.C. 331(d) and (a). Based on its labeled intended uses, “PIMENT Doux plus FACE WHITENING CREAM” is a “drug” as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Specifically, this product is intended for use as a skin bleaching drug product.

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_190.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).